This SuperSeries is composed of the SubSeries listed below.
Overall design: Refer to individual Series
| Accession | PRJNA352132; GEO: GSE89418 |
| Type | Umbrella project |
| Publications | Vo LT et al., "Regulation of embryonic haematopoietic multipotency by EZH1.", Nature, 2018 Jan 25;553(7689):506-510 |
| Submission | Registration date: 2-Nov-2016
Boston Children's Hospital |
| Relevance | Superseries |
Project Data:
| Resource Name | Number
of Links |
|---|
| Sequence data |
| SRA Experiments | 58 |
| Publications |
| PubMed | 1 |
| PMC | 1 |
| Other datasets |
| BioSample | 58 |
| GEO DataSets | 4 |
EZH1 as a key epigenetic barrier to definitive haematopoiesis during embryonic development encompasses the following 3 sub-projects:
| Project Type | Number of Projects |
| Epigenomics | 2 |
BioProject
accession | Name | Title |
|---|
| PRJNA352134 | ATAC-seq analysis in 5F cells and AGM cells with EZH1 depletion | ATAC-seq analysis in 5F cells and AGM cells with EZH1 depletion (Boston Children's Hospital) | | PRJNA352136 | Homo sapiens | ChIP-seq analysis of EZH1, H3K4me3 and H3K27me3 in 5F cells (Boston Children's Hospital) |
|
| Transcriptome or Gene expression | 1 |
BioProject
accession | Name | Title |
|---|
| PRJNA352135 | RNA-seq analysis of EZH1 knockdown in 5F cells, or EZH1 heterozygous and homozygous knockout YS and AGM cells | RNA-seq analysis of EZH1 knockdown in 5F cells, or EZH1 heterozygous and homozygous knockout YS and AGM cells (Boston Children's Hospital) |
|